Need professional-grade analysis? Visit stockanalysis.com
$7.70M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Gelteq Limited Ordinary Shares (GELS) Price Performance
Gelteq Limited Ordinary Shares (GELS) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $0.68, down 7.39% from the previous close.
Over the past year, GELS has traded between a low of $0.66 and a high of $2.95. The stock has lost 71.0% over this period. It is currently 77.1% below its 52-week high.
Gelteq Limited Ordinary Shares has a market capitalization of $7.70M.
About Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Compare Gelteq Limited Ordinary Shares
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $413,132
- EBITDA
- $-3,843,531
- Profit Margin
- N/A
- EPS (TTM)
- -0.49
- Book Value
- 1.10
Technical Indicators
- 52 Week High
- $3.51
- 52 Week Low
- $0.64
- 50 Day MA
- $0.76
- 200 Day MA
- $1.16
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 18.63
- Price/Book
- 0.65
- Enterprise Value
- $11.57M